You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 9,119,859


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,119,859 protect, and when does it expire?

Patent 9,119,859 protects XTORO and is included in one NDA.

This patent has twenty-two patent family members in sixteen countries.

Summary for Patent: 9,119,859
Title:Methods for treating otic infections
Abstract: The present invention relates to methods for treating an ophthalmic, otic, or nasal infection comprising treating the infected tissue with a composition comprising finafloxacin or a finafloxacin derivative. The present invention also relates to antimicrobial compositions comprising finafloxacin or a finafloxacin derivative. The compositions are suitable for the treatment of ophthalmic, otic, or nasal infections.
Inventor(s): Stroman; David W. (Irving, TX), Chowhan; Masood A. (Arlington, TX), Appell; Kenneth C. (Burleson, TX)
Assignee: Alcon Research, Ltd. (Fort Worth, TX)
Application Number:13/967,897
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

United States Patent 9,119,859: A Detailed Analysis of Scope and Claims

Overview of the Patent

United States Patent 9,119,859, titled "Methods for treating otic infections," was granted to its inventors for innovative methods in the treatment of otic (ear) infections. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background and Context

The patent in question addresses a significant medical need: the treatment of otic infections. Otic infections can be severe and require effective treatment to prevent complications. The invention described in this patent provides new methods for treating these infections, which is a critical advancement in the field of otolaryngology.

Patent Claims

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims are crucial as they outline what the inventors consider to be the novel and non-obvious aspects of their invention.

  • Claim 1: This claim typically sets the broadest scope of the invention, describing the method for treating an otic infection using a specific composition.
    • For example, "A method for treating an otic infection, comprising administering a composition comprising finafloxacin to the infected tissue"[5].

Dependent Claims

Dependent claims further narrow down the scope of the invention by adding additional limitations or specifics to the independent claims.

  • Claim 2: This might include specific concentrations of finafloxacin or the method of administration.
    • For instance, "The method of claim 1, wherein the composition comprises finafloxacin in a concentration of about 0.3% to about 1.0% w/v"[5].

Scope of the Invention

The scope of the invention is defined by the claims and the detailed description provided in the patent specification.

Composition and Administration

The patent describes methods involving the use of finafloxacin, a fluoroquinolone antibiotic, in treating otic infections. The composition and method of administration are key aspects of the invention.

  • Finafloxacin: This antibiotic is known for its efficacy against a broad spectrum of bacteria, making it suitable for treating various types of otic infections[5].

Clinical Significance

The invention is clinically significant because it provides a targeted and effective treatment for otic infections, which can reduce the risk of complications and improve patient outcomes.

Patent Landscape

Prior Art

The patent landscape for otic infection treatments includes a variety of existing methods and compositions. The inventors of US 9,119,859 had to demonstrate that their method was novel and non-obvious over the existing prior art.

  • Prior Art Keywords: The patent lists keywords such as "finafloxacin," "compositions," and "ophthalmic," indicating the relevance of these terms in the broader context of treating infections[5].

Competitive Landscape

The competitive landscape for otic infection treatments is dynamic, with various pharmaceutical companies and researchers developing new treatments.

  • Market Need: The demand for effective treatments for otic infections drives innovation in this field. Patents like US 9,119,859 play a crucial role in protecting intellectual property and encouraging further research and development.

Legal and Regulatory Aspects

Patent Validity and Enforcement

The validity and enforceability of the patent are critical for the inventors and assignees. The Patent Trial and Appeal Board (PTAB) and other legal mechanisms can be used to challenge the validity of patents, as established by the Leahy-Smith America Invents Act (AIA)[1].

  • Inter Partes Review (IPR): This is a common mechanism for challenging patent validity. The PTAB reviews the patent claims to determine if they are valid over the prior art[1].

Compliance with Patent Law

The patent must comply with U.S. patent law, including the requirements for patentability such as novelty, non-obviousness, and utility.

  • Subject Matter Eligibility: The patent claims must not be directed to ineligible subject matter, such as laws of nature, natural phenomena, or abstract ideas, unless they contain an inventive concept that transforms the nature of the claim[1].

Economic and Social Impact

Economic Impact

Patents like US 9,119,859 can have significant economic impacts by protecting intellectual property and encouraging investment in research and development.

  • Research and Development: The protection afforded by patents can incentivize companies to invest in R&D, leading to further innovations and economic growth[3].

Social Impact

The social impact of this patent is substantial, as it contributes to the development of effective treatments for otic infections, improving public health.

  • Public Health: Effective treatments for otic infections can reduce morbidity and mortality rates, improving the quality of life for patients and reducing healthcare costs[5].

Key Takeaways

  • Novel Method: The patent describes a novel method for treating otic infections using finafloxacin.
  • Clinical Significance: The invention is clinically significant due to its efficacy in treating otic infections.
  • Patent Landscape: The patent operates within a dynamic landscape of existing treatments and ongoing research.
  • Legal and Regulatory Compliance: The patent must comply with U.S. patent law and can be subject to legal challenges.
  • Economic and Social Impact: The patent has significant economic and social impacts by protecting intellectual property and improving public health.

FAQs

What is the main claim of US 9,119,859?

The main claim of US 9,119,859 involves a method for treating an otic infection using a composition comprising finafloxacin.

How does the patent comply with U.S. patent law?

The patent complies with U.S. patent law by meeting the requirements for novelty, non-obviousness, and utility, and by not being directed to ineligible subject matter unless it contains an inventive concept.

What is the clinical significance of this patent?

The patent is clinically significant because it provides a targeted and effective treatment for otic infections, which can improve patient outcomes and reduce the risk of complications.

How does the PTAB impact the validity of this patent?

The PTAB can review the patent claims through mechanisms like Inter Partes Review (IPR) to determine their validity over the prior art.

What is the economic impact of this patent?

The patent can have a significant economic impact by protecting intellectual property, encouraging investment in research and development, and contributing to economic growth.

Sources

  1. Congressional Research Service, "The Patent Trial and Appeal Board and Inter Partes Review," May 28, 2024.
  2. Administrative Conference of the United States, "U.S. Patent Small Claims Court," April 28, 2022.
  3. United States Patent and Trademark Office, "Patent Claims Research Dataset," August 28, 2017.
  4. New York Public Library, "How to Search for an Historical U.S. Patent," December 6, 2024.
  5. Google Patents, "US9119859B2 - Methods for treating otic infections," May 5, 2015.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,119,859

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Fonseca Biosciences XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No 9,119,859 ⤷  Subscribe TREATMENT OF ACUTE OTITIS EXTERNA ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.